| The somatic genomic landscape of glioblastoma CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ... cell 155 (2), 462-477, 2013 | 5312 | 2013 |
| Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ... Cell 164 (3), 550-563, 2016 | 2142 | 2016 |
| Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice EC Holland, J Celestino, C Dai, L Schaefer, RE Sawaya, GN Fuller Nature genetics 25 (1), 55-57, 2000 | 1142 | 2000 |
| Malignant gliomas: MR imaging spectrum of radiation therapy-and chemotherapy-induced necrosis of the brain after treatment AJ Kumar, NE Leeds, GN Fuller, P Van Tassel, MH Maor, RE Sawaya, ... Radiology 217 (2), 377-384, 2000 | 824 | 2000 |
| I nternational S ociety of N europathology‐H aarlem C onsensus G uidelines for N ervous S ystem T umor C lassification and G rading DN Louis, A Perry, P Burger, DW Ellison, G Reifenberger, A von Deimling, ... Brain pathology 24 (5), 429-435, 2014 | 696 | 2014 |
| Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma FF Lang, C Conrad, C Gomez-Manzano, WKA Yung, R Sawaya, ... Journal of clinical oncology 36 (14), 1419-1427, 2018 | 657 | 2018 |
| Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice JF De Groot, G Fuller, AJ Kumar, Y Piao, K Eterovic, Y Ji, CA Conrad Neuro-oncology 12 (3), 233-242, 2010 | 608 | 2010 |
| cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading DN Louis, P Wesseling, K Aldape, DJ Brat, D Capper, IA Cree, C Eberhart, ... Brain Pathology 30 (4), 844-856, 2020 | 555 | 2020 |
| Limitations of stereotactic biopsy in the initial management of gliomas RJ Jackson, GN Fuller, D Abi-Said, FF Lang, ZL Gokaslan, WM Shi, ... Neuro-oncology 3 (3), 193-200, 2001 | 525 | 2001 |
| cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas DJ Brat, K Aldape, H Colman, D Figrarella-Branger, GN Fuller, C Giannini, ... Acta neuropathologica 139, 603-608, 2020 | 513 | 2020 |
| Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results FF Lang, JM Bruner, GN Fuller, K Aldape, MD Prados, S Chang, ... Journal of Clinical Oncology 21 (13), 2508-2518, 2003 | 490 | 2003 |
| Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. PA Humphrey, AJ Wong, B Vogelstein, MR Zalutsky, GN Fuller, GE Archer, ... Proceedings of the National Academy of Sciences 87 (11), 4207-4211, 1990 | 479 | 1990 |
| Sacral chordoma: 40-year experience at a major cancer center JE York, A Kaczaraj, D Abi-Said, GN Fuller, JM Skibber, NA Janjan, ... Neurosurgery 44 (1), 74-79, 1999 | 461 | 1999 |
| Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype K Gabrusiewicz, B Rodriguez, J Wei, Y Hashimoto, LM Healy, SN Maiti, ... JCI insight 1 (2), 2016 | 457 | 2016 |
| A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors LL Chen, JC Trent, EF Wu, GN Fuller, L Ramdas, W Zhang, AK Raymond, ... Cancer research 64 (17), 5913-5919, 2004 | 428 | 2004 |
| Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway J Fueyo, R Alemany, C Gomez-Manzano, GN Fuller, A Khan, CA Conrad, ... Journal of the National Cancer Institute 95 (9), 652-660, 2003 | 411 | 2003 |
| Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas AB Heimberger, M Abou-Ghazal, C Reina-Ortiz, DS Yang, W Sun, W Qiao, ... Clinical Cancer Research 14 (16), 5166-5172, 2008 | 377 | 2008 |
| Ink4a-Arf Loss Cooperates with KRas Activation in Astrocytes and Neural Progenitors to Generate Glioblastomas of Various Morphologies … L Uhrbom, C Dai, JC Celestino, MK Rosenblum, GN Fuller, EC Holland Cancer research 62 (19), 5551-5558, 2002 | 371 | 2002 |
| Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro M Yamamoto, S Mohanam, R Sawaya, GN Fuller, M Seiki, H Sato, ... Cancer Research 56 (2), 384-392, 1996 | 364 | 1996 |
| Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target J Wei, A Marisetty, B Schrand, K Gabrusiewicz, Y Hashimoto, M Ott, ... The Journal of clinical investigation 129 (1), 137-149, 2019 | 317 | 2019 |